Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, U.S.A.
Department of Surgical Services, St. Jude Children's Research Hospital, Memphis, Tennessee, U.S.A.
Ophthalmic Plast Reconstr Surg. 2024;40(3):260-265. doi: 10.1097/IOP.0000000000002558. Epub 2023 Nov 16.
To compare the orbital volume between enucleated and contralateral, uninvolved orbits over a 5-year period in patients with unilateral retinoblastoma who underwent enucleation with hydroxyapatite (HA) implant placement by a single surgeon.
A retrospective review was performed on the clinical records and radiographic images of unilateral retinoblastoma patients who underwent enucleation with primary HA implantation from 2003 to 2020 at a single institution. Bilateral orbital volume measurements were taken from the initial postoperative MRI scan and again at 1- and 5-years postenucleation. The main outcome measure was the longitudinal change in volume difference (∆𝑉). The implant size, age at enucleation, and sex were also evaluated. A linear mixed-effect model was used for analysis.
A total of 124 patients (73 males) with HA implants following enucleation were included. Overall, the unaffected orbit trended toward having a greater volume compared with the enucleated orbit, but this was not statistically significant (β = 0.003; p = 0.122). The mean age at enucleation was 2.4 years. The median time between enucleation and the initial, 1-year, and 5-year postoperative MRIs was 6 months, 17 months, and 55 months, respectively. There was no statistical correlation between age at enucleation, gender, implant size, or orbital volume at any time points ( p > 0.05).
Patients treated with enucleation and primary HA implant placement for unilateral retinoblastoma did not display significant asymmetry in orbital volume on 5-year postenucleation MRIs, suggesting that HA implants promote orbital growth comparable to a nonenucleated orbit in the pediatric population.
比较 5 年内单侧视网膜母细胞瘤患者行眼球摘除术联合羟基磷灰石(HA)植入术后患侧与对侧未受累眼眶的眶容积。
对单中心 2003 年至 2020 年行眼球摘除术联合 HA 植入术的单侧视网膜母细胞瘤患者的临床记录和影像学资料进行回顾性分析。从初次术后 MRI 扫描开始,对双侧眶容积进行测量,并分别在眼球摘除术后 1 年和 5 年进行测量。主要观察指标为体积差(∆V)的纵向变化。还评估了植入物大小、眼球摘除年龄和性别。采用线性混合效应模型进行分析。
共纳入 124 例(73 例男性)行眼球摘除术联合 HA 植入术后患者。总体而言,未受累眶的体积趋势大于患侧,但无统计学意义(β=0.003;p=0.122)。眼球摘除时的平均年龄为 2.4 岁。眼球摘除后初次、1 年和 5 年 MRI 的中位时间分别为 6 个月、17 个月和 55 个月。眼球摘除年龄、性别、植入物大小和任何时间点的眶容积之间均无统计学相关性(p>0.05)。
行眼球摘除术联合 HA 植入术治疗单侧视网膜母细胞瘤的患者,在术后 5 年的 MRI 上未显示眶容积明显不对称,提示 HA 植入物在儿童人群中可促进眼眶生长,与未行眼球摘除的眼眶相似。